USPTO serial 88806837
XARACOLL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 2, 2021
- Examiner
- MAYES, LAURIE ANN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with XARACOLL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $650
Owner
Innocoll Pharmaceuticals Limited
Athlone, Co. Roscommon, IE
Innocoll Pharmaceuticals Limited
Athlone, Co. Roscommon, IE
Innocoll Pharmaceuticals Limited
Athlone, Co. Roscommon, IE
GURNET FINANCE (JERSEY) LIMITED
ST. HELIER, JE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Camille M. Miller
Camille M. Miller COZEN O'CONNOR1650 MARKET STREETSUITE 2800PHILADELPHIA, PA 19103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical implant device in the nature of surgical implants of living tissue specifically comprised of a collagen and extracellular matrix composition; semi-liquid matrices in the nature of implantable scaffolds comprising living tissues for maintaining tissue contour; surgical and medical implant devices in the nature of implants of living collagen | ACTIVE | — |
| 010 | semi-liquid matrices in the nature of implantable scaffolds comprising artificial materials for maintaining tissue contour; supportive surgical and medical patches in the nature of drug delivery patches sold without medication for use in skin repair and skin improvement; supportive surgical and medical implants comprised of artificial materials for use in skin repair and skin improvement; surgical and medical implant devices in the nature of implants of non-living collagen; collagen constructs for medical, surgical or veterinary purposes in the nature of implantable scaffolds comprising non-living collagen; non-living collagen based surgical implants for management of post-operative pain; non-living collagen based surgical implants for wound management | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Innocoll Pharmaceuticals Limited
- Other trademarks owned by Innocoll Pharmaceuticals Limited
- Other trademarks owned by Innocoll Pharmaceuticals Limited
- Other trademarks owned by GURNET FINANCE (JERSEY) LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named XARACOLL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 2, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 31, 2025 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 8, 2023 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Feb 2, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 17, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 17, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 28, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 14, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 13, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 13, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 6, 2020 | ALIE | ASSIGNED TO LIE | — |
| Sep 29, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 26, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 26, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 26, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 20, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 20, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 19, 2020 | ALIE | ASSIGNED TO LIE | — |
| May 13, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 12, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 26, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 26, 2020 | NWAP | NEW APPLICATION ENTERED | — |